Study confirms preventative maintenance program for CSafe RKNs is instrumental in preserving high-quality operational performance, regardless of container age | June 2019
Maintenance of mechanical systems is critical for consistent operational performance. This is understood across all industries ranging from automotive and aerospace to oil and chemical manufacturing. Cold chain transportation is no different, and CSafe understood this, and thus developed and deployed a robust Preventative Maintenance Rebuild (PMR) program before launching its CSafe RKN active container. This white paper is an updated version of an earlier study titled, “Maintenance of Active ULD’s and It’s Positive Impact on Performance and Longevity”. The earlier paper examined the hypothesis that all CSafe active containers operate at a consistent and optimal performance level, regardless of age, as result of the PMR program. In the original study, a random sampling of containers that shipped together on a multi-container lease, performed almost identically. To reconfirm the same hypothesis, this new study recruited the oldest container from the original study and compared it to a new random sampling of containers shipped together on another multi-container lease. Again, the data collected from the new selection of containers demonstrated virtually identical operational performance across each of the containers utilized.
Not all temperature controlled containers are equal when it comes to thermal performance – is your vital pharmaceutical shipment at risk? | May 2019
Although Active Temperature Controlled Containers (ATCC) for air cargo transport may rely on similar mechanical components to manage the heating and cooling of the cargo compartment, the interaction between these components and the physical design of the container make a significant difference in the operational performance. This study shows the difference that airflow design and the recirculation pathway have on critical thermal mapping characteristics within an ATCC cargo compartment, and thus demonstrates that not all containers are created equal when it comes to thermal performance.
A question of choice and suitability | December 2016
The pharma and biotech industries are continuously seeking reliable ways of ascertaining the location, payload condition, and ambient environment surrounding their temperature-sensitive products during transit. It’s rapidly becoming a regulatory, safety, security, and commercial issue.
An Example of GDP Collaboration | September 2016
Choosing the right route and packaging is one thing – but how well do you know your supply chain partners in terms of their capabilities in Good Distribution Practice standards? Arguably this is just as important since we know that even the best designed and manufactured packaging solution can easily fail if poorly handled by untrained staff who are not aware of the peculiar needs of your shipment.
Lifecycle Logistics | August 2016
For most pharmaceutical companies (and perhaps those particularly operating under the regulatory guidance of the EU), a key challenge is the ability to create and maintain an innovative and competitive distribution channel strategy. This means looking beyond the traditional cost components of ‘transportation’ and taking a wider view of all the elements that go to make up the total cost of distribution.